US FDA Approves Jardiance for the Treatment of Adults with Chronic Kidney Disease
RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 22, 2023 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Jardiance® (empagliflozin) 10 mg tablets to reduce the risk of sustained decline in estimated glomerular filtration rate... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 22, 2023 Category: Drugs & Pharmacology Source Type: news
FDA Approves Another SGLT2 Inhibitor for Treating CKD
(MedPage Today) -- The SGLT2 inhibitor empagliflozin (Jardiance) nabbed a new indication for the treatment of adults with chronic kidney disease (CKD) regardless of diabetes status, Boehringer Ingelheim and Eli Lilly announced.
Data from the phase... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 22, 2023 Category: Cardiology Source Type: news
Biden targets diabetes drug Jardiance, blood thinner Eliquis and 8 others for Medicare price talks
President Joe Biden says for many Americans the cost of one drug can be “the difference between life and death” as his administration announces the first drugs that’ll be targeted for price negotiations in an effort to cut Medicare costs (Source: ABC News: Health)
Source: ABC News: Health - August 29, 2023 Category: Consumer Health News Tags: Health Source Type: news
The 10 Drugs Medicare Can Negotiate Were Just Announced. These Pharma Stocks Are Impacted
Eliquis, Jardiance, and Stelara are among the first of 10 different drugs that are now subject to Medicare price negotiations following the passing of the Inflation Reduction Act.#medicare (Source: Reuters: Health)
Source: Reuters: Health - August 29, 2023 Category: Consumer Health News Source Type: news
Biden targets diabetes drug Jardiance, blood thinner Eliquis and 8 others for Medicare price talks
By TOM MURPHY, AMANDA SEITZ and CHRIS MEGERIAN | Associated Press WASHINGTON — The blood thinner Eliquis and popular diabetes treatments including Jardiance are among the first drugs that will be targeted for price negotiations in an effort to cut Medicare costs. President Joe Biden’s…#tommurphy #amanda #chris #eliquis #medicare #joebidens #merck #amgen #entresto #novartis (Source: Reuters: Health)
Source: Reuters: Health - August 29, 2023 Category: Consumer Health News Source Type: news
Here Are the First 10 Drugs Biden Will Target for Price Negotiations
WASHINGTON (AP) — The popular diabetes treatment Jardiance and the blood thinner Eliquis are among the first drugs that will be targeted for price negotiations in effort to cut Medicare costs.
President Joe Biden’s administration on Tuesday released a list of 10 drugs for which the federal government will take a first-ever step: negotiating drug prices directly with the manufacturer.
[time-brightcove not-tgx=”true”]
The move is expected to cut costs for some patients but faces litigation from the drugmakers and heavy criticism from Republican lawmakers. It’s also a centerpiece of t...
Source: TIME: Health - August 29, 2023 Category: Consumer Health News Authors: TOM MURPHY, AMANDA SEITZ and CHRIS MEGERIAN / AP Tags: Uncategorized wire Source Type: news
Eliquis and Jardiance Among First Drugs Picked for Medicare Price Negotiations
The Biden administration ’s announcement was an important moment for Democrats, who have campaigned on a promise to lower the cost of prescription drugs. (Source: NYT)
Source: NYT - August 29, 2023 Category: American Health Authors: Sheryl Gay Stolberg and Rebecca Robbins Tags: Drugs (Pharmaceuticals) Medicare Inflation Reduction Act of 2022 Biden, Joseph R Jr Health and Human Services Department Health Insurance and Managed Care Prices (Fares, Fees and Rates) Democratic Party United States Politics and Governmen Source Type: news
Stocks trending in afternoon trading: Beyond Meat, Eli Lilly, and Palantir
Corporate results were driving big moves in a variety of stocks on Tuesday afternoon, while a positive development on Novo Nordisk's (NVO) Wegovy weight-loss drug sent big pharma stocks soaring. Below is a breakdown of some of the biggest movers on Yahoo Finance's trending tickers page. Eli Lilly…#novonordisk #nvo #yahoofinance #elililly #lly #davidricks #mounjaro #jardiance #anatashkenazi #beyondmeat (Source: Reuters: Health)
Source: Reuters: Health - August 8, 2023 Category: Consumer Health News Source Type: news
Europe Approves Empagliflozin for Chronic Kidney Disease Europe Approves Empagliflozin for Chronic Kidney Disease
The SGLT2 inhibitor empagliflozin (Jardiance) was approved by European regulators for treating adults with chronic kidney disease. The FDA is reviewing a new drug application for this indication.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - July 27, 2023 Category: Internal Medicine Tags: Diabetes & Endocrinology News Alert Source Type: news
FDA Approves Jardiance (empagliflozin) for the Treatment of Type 2 Diabetes in Children 10 Years and Older
RIDGEFIELD, Conn. and INDIANAPOLIS, June 21, 2023 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Jardiance (empagliflozin) 10 mg and 25 mg tablets to lower blood sugar along with diet and exercise in children 10 years and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 21, 2023 Category: Drugs & Pharmacology Source Type: news
FDA Approves New Drugs to Treat Type 2 Diabetes in Kids
WEDNESDAY, June 21, 2023 -- The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 and up.
The approvals of Jardiance (empagliflozin) and Synjardy... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 21, 2023 Category: General Medicine Source Type: news
FDA Approves New Drugs, Jardiance and Synjardy to Treat Type 2 Diabetes in Kids
WEDNESDAY, June 21, 2023 -- The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 and up.
The approvals of Jardiance (empagliflozin) and Synjardy... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 21, 2023 Category: General Medicine Source Type: news
FDA OKs Empagliflozin for Children With Type 2 Diabetes FDA OKs Empagliflozin for Children With Type 2 Diabetes
Both Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin) were approved for children aged 10 years and older.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 21, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
First SGLT2 Inhibitor Approved for Kids With Type 2 Diabetes
(MedPage Today) -- Two empagliflozin-containing treatments were FDA approved for pediatric type 2 diabetes, the agency announced on Tuesday.
Once-daily empagliflozin (Jardiance) and empagliflozin/metformin hydrochloride (Synjardy) are now indicated... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 21, 2023 Category: American Health Source Type: news
FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes
June 20, 2023 -- Today, the U.S. Food and Drug Administration approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) as additions to diet and exercise to improve blood sugar control in children 10 years and older... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 20, 2023 Category: Drugs & Pharmacology Source Type: news
